Bedel Financial Consulting’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-15
Closed -$4K 517
2022
Q1
$4K Hold
15
﹤0.01% 800
2021
Q4
$3K Hold
15
﹤0.01% 841
2021
Q3
$3K Hold
15
﹤0.01% 840
2021
Q2
$3K Hold
15
﹤0.01% 831
2021
Q1
$3K Hold
15
﹤0.01% 802
2020
Q4
$3K Hold
15
﹤0.01% 711
2020
Q3
$2K Hold
15
﹤0.01% 714
2020
Q2
$1K Hold
15
﹤0.01% 739
2020
Q1
$1K Hold
15
﹤0.01% 745
2019
Q4
$1K Hold
15
﹤0.01% 729
2019
Q3
$1K Buy
+15
New +$988 ﹤0.01% 709

Other funds holding INSP

Bedel Financial Consulting's INSP Position: Q2 2022 in Review

Bedel Financial Consulting sold out of Inspire Medical Systems (INSP) in Q2 2022, closing a stake of 15 shares — an estimated $4K sold.

Bedel Financial Consulting first reported a position in INSP in Q3 2019 and held it in 11 quarters. The position peaked at $4K in Q1 2022. 286 funds tracked by Wall St. Rank hold INSP as of Q2 2022.

  • Bedel Financial Consulting reported no remaining Inspire Medical Systems position as of Q2 2022 after selling out during the quarter.
  • Bedel Financial Consulting sold 15 Inspire Medical Systems shares in Q2 2022, an estimated $4K.
  • Bedel Financial Consulting first reported a position in Inspire Medical Systems in Q3 2019 and held it in 11 quarters.
  • Bedel Financial Consulting's Inspire Medical Systems position peaked at $4K in Q1 2022.
  • 286 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q2 2022.

Based on Bedel Financial Consulting's 13F filing for Q2 2022, filed 4 Aug 2022.